GSK3B and neuroblastoma: Remarkably, the same compound proved to inhibit GSK-3β in human neuroblastoma SH-SY5Y cells at 1–5 μM concentrations and reduce τ phosphorylation at Ser396 in mouse hippocampal primary neurons at 20 μM [115].